May 13 Medical device maker C.R. Bard Inc
will pay about $48.3 million to resolve allegations it
made illegal payments to hospitals and physicians to entice them
to buy its radiation treatment for prostate cancer, the Justice
The illegal payments allegedly took the form of grants,
rebates, conference fees, marketing assistance and free medical
equipment that Bard provided between 1998 and 2006 to customers
who used its brachytherapy seeds to treat prostate cancer, DOJ
Hospitals submitted bills for the seeds to the Medicare
program for the elderly, in violation of the False Claims Act,
A Bard spokesman did not immediately return a phone call
The civil settlement resolves a lawsuit filed in U.S.
District Court for the Northern District of Georgia by
whistleblower Julie Darity, a former Bard manager.
Darity will receive about $10.1 million as her share of the
civil settlement, DOJ said.
Bard has agreed to pay an additional $2.2 million to the
government and to take remedial steps to improve its compliance
program as part of a non-prosecution agreement, DOJ said.